SETPOINT2

This application provides information about a clinical trial conducted by Heidelberg University and Maine Medical Center funded by a Patient-Centered Research Institute (PCORI) Award.

This application requires login credentials and is intended for investigators and coordinators working on the SETPOINT2 trial.

Stroke-related Early Tracheostomy vs. Prolonged Orotracheal Intubation in Neurocritical care Trial 2 (SETPOINT2) is a multicenter, prospective, randomized, observer-blinded, controlled trial that aims to answer the question “Does early tracheostomy as opposed to prolonged intubation in ventilated patients with severe stroke improve outcome 6 months after admission?”.